Home News Team Current Studies Publications Events Cooperations Contact
© Christian Mueller, 2012 - 2017  │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: August 2017
Dr. Tobias Reichlin Dr. Tobias Breidthardt
Background:  The GALACTIC TRIAL (Goal Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study) is a  prospective, randomized, interventional controlled trial designed to determine the optimal treatment for acute heart  failure patients in the non-ICU setting. The study focuses on an aggressive decrease in preload and afterload, by means  of a therapeutic strategy using high dose nitrates, hydralazine, ACE inhibiors and or ARBs. Soon, Galactic will expand its  satellite centers to Brazil and the Czech Republic, bringing us closer to reflecting a global population and finding   Trial Registration No: NCT00512759 (clinicaltrials.gov)   Link  Trial Status: Enrollment active  Enrolling Centers:  Switzerland Worldwide: University Hospital Basel  Brazil: Sao Paulo  Cantonal Hospital Aarau (Enrollment finished)  Spain: Hospital de la Santa Creu i Sant Pau  Cantonal Hospital Luzern (Enrollment finished)  Germany: Nürnberg, Mainz  Hospital St. Gallen  Coming Soon in Bulgaria, Sofia:  Universitiy Hospital Tsaritsa Yoanna-Isul National Transport Hospital Tsar Boris III 5th Multifunctional Hospit. for Actice Treatm.  Universitiy Hospital Alexandrovska  Core Study Team: 
Dr. Zaid Sabti Michael Freese Dr. Samyut Shresta Janine Vögele Natascha Herr Nikola Kozhuharov NEWSLETTER Dayana Flores Carmela Schumacher Jonas Hilti Deborah Schneider Sara Barata Ayman Alhussini